abstract |
6- and 7-amino isoquinoline compounds are provided that influence, inhibit or reduce the action of a kinase. Phar-maceutical compositions including therapeutically effective amounts of the 6- and 7-aminoisoquinoline compounds and pharma-ceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, obesity and glaucoma are also provided. |